Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome

Advances in Biological Regulation

Volumn 52, Issue 1, 2012, Pages 196-203

  Boultwood, Jacqueline ^a   Pellagatti, Andrea ^a   Wainscoat, James S ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865636769     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2011.09.008     Document Type: Review

References (53)

1. Amsterdam A., Sadler K.C., Lai K., Farrington S., Bronson R.T., Lees J.A., et al. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol 2004, 2. E139.
2. Barlow J.L., Drynan L.F., Hewett D.R., Holmes L.R., Lorenzo-Abalde S., Lane A.L., et al. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat Med. 2010, 16:59-66.
3. Boehme K.A., Blattner C. Regulation of p53-insights into a complex process. Crit Rev Biochem Mol Biol. 2009, 44:367-392.
4. Boultwood J., Lewis S., Wainscoat J.S. The 5q-syndrome. Blood 1994, 84:3253-3260.
5. Boultwood J., Fidler C., Strickson A.J., Watkins F., Gama S., Kearney L., et al. Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome. Blood 2002, 99:4638-4641.
6. Boultwood J., Pellagatti A., Cattan H., Lawrie C.H., Giagounidis A., Malcovati L., et al. Gene expression profiling of CD34+ cells in patients with the 5q- syndrome. Br J Haematol. 2007, 139:578-589.
7. Chen D., Zhang Z., Li M., Wang W., Li Y., Rayburn E.R., et al. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene 2007, 26:5029-5037.
8. Danilova N., Sakamoto K.M., Lin S. Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood 2008, 112:5228-5237.
9. Deisenroth C., Zhang Y. Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway. Oncogene 2010, 29:4253-4260.
10. Doherty L., Sheen M.R., Vlachos A., Choesmel V., O'Donohue M.F., Clinton C., et al. Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia. Am J Hum Genet. 2010, 86:222-228.
11. Draptchinskaia N., Gustavsson P., Andersson B., Pettersson M., Willig T.N., Dianzani I., et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet. 1999, 21:169-175.
12. Dutt S., Narla A., Lin K., Mullally A., Abayasekara N., Megerdichian C., et al. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood 2011, 117:2567-2576.
13. Ebert B.L., Lee M.M., Pretz J.L., Subramanian A., Mak R., Golub T.R., et al. An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray. Blood 2005, 105:4620-4626.
14. Ebert B.L., Pretz J., Bosco J., Chang C.Y., Tamayo P., Galili N., et al. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 2008, 451:335-339.
15. Flygare J., Karlsson S. Diamond-Blackfan anemia: erythropoiesis lost in translation. Blood 2007, 109:3152-3154.
16. Flygare J., Aspesi A., Bailey J.C., Miyake K., Caffrey J.M., Karlsson S., et al. Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits. Blood 2007, 109:980-986.
17. Fumagalli S., Di Cara A., Neb-Gulati A., Natt F., Schwemberger S., Hall J., et al. Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat Cell Biol. 2009, 11:501-508.
18. Gazda H.T., Kho A.T., Sanoudou D., Zaucha J.M., Kohane I.S., Sieff C.A., et al. Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia. Stem Cells 2006, 24:2034-2044.
19. Giagounidis A.A., Germing U., Wainscoat J.S., Boultwood J., Aul C. The 5q- syndrome. Hematology 2004, 9:271-277.
20. Gregory L.A., Aguissa-Toure A.H., Pinaud N., Legrand P., Gleizes P.E., Fribourg S. Molecular basis of Diamond-Blackfan anemia: structure and function analysis of RPS19. Nucleic Acids Res. 2007, 35:5913-5921.
21. Gu J., Kawai H., Nie L., Kitao H., Wiederschain D., Jochemsen A.G., et al. Mutual dependence of MDM2 and MDMX in their functional inactivation of p53. J Biol Chem. 2002, 277:19251-19254.
22. Hamaguchi I., Ooka A., Brun A., Richter J., Dahl N., Karlsson S. Gene transfer improves erythroid development in ribosomal protein S19-deficient Diamond-Blackfan anemia. Blood 2002, 100:2724-2731.
23. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387:296-299.
24. Holzel M., Orban M., Hochstatter J., Rohrmoser M., Harasim T., Malamoussi A., et al. Defects in 18 S or 28 S rRNA processing activate the p53 pathway. J Biol Chem. 2010, 285:6364-6370.
25. Jackson M.W., Berberich S.J. MdmX protects p53 from Mdm2-mediated degradation. Mol Cell Biol. 2000, 20:1001-1007.
26. Jadersten M., Saft L., Smith A., Kulasekararaj A., Pomplun S., Gohring G., et al. TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression. J Clin Oncol. 2011, 29:1971-1979.
27. Jones N.C., Lynn M.L., Gaudenz K., Sakai D., Aoto K., Rey J.P., et al. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat Med. 2008, 14:125-133.
28. Lajtha L.G., Oliver R. A kinetic model of the erythron. Proc R Soc Med. 1961, 54:369-371.
29. Linares L.K., Hengstermann A., Ciechanover A., Muller S., Scheffner M. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. Proc Natl Acad Sci U S A 2003, 100:12009-12014.
30. Lindstrom M.S., Nister M. Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation. PLoS One 2010, 5:e9578.
31. Lipton J.M., Atsidaftos E., Zyskind I., Vlachos A. Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry. Pediatr Blood Cancer 2006, 46:558-564.
32. Liu J.M., Ellis S.R. Ribosomes and marrow failure: coincidental association or molecular paradigm?. Blood 2006, 107:4583-4588.
33. Lohrum M.A., Ludwig R.L., Kubbutat M.H., Hanlon M., Vousden K.H. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 2003, 3:577-587.
34. MacInnes A.W., Amsterdam A., Whittaker C.A., Hopkins N., Lees J.A. Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc Natl Acad Sci U S A 2008, 105:10408-10413.
35. McGowan K.A., Li J.Z., Park C.Y., Beaudry V., Tabor H.K., Sabnis A.J., et al. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet. 2008, 40:963-970.
36. Menne T.F., Goyenechea B., Sanchez-Puig N., Wong C.C., Tonkin L.M., Ancliff P.J., et al. The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nat Genet. 2007, 39:486-495.
37. Narla A., Ebert B.L. Ribosomopathies: human disorders of ribosome dysfunction. Blood 2010, 115:3196-3205.
38. Ohene-Abuakwa Y., Orfali K.A., Marius C., Ball S.E. Two-phase culture in Diamond Blackfan anemia: localization of erythroid defect. Blood 2005, 105:838-846.
39. Pellagatti A., Hellstrom-Lindberg E., Giagounidis A., Perry J., Malcovati L., Della Porta M.G., et al. Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes. Br J Haematol. 2008, 142:57-64.
40. Pellagatti A., Marafioti T., Paterson J.C., Barlow J.L., Drynan L.F., Giagounidis A., et al. Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome. Blood 2010, 115:2721-2723.
41. Peller S., Frenkel J., Lapidot T., Kahn J., Rahimi-Levene N., Yona R., et al. The onset of p53-dependent apoptosis plays a role in terminal differentiation of human normoblasts. Oncogene 2003, 22:4648-4655.
42. Riley T., Sontag E., Chen P., Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol. 2008, 9:402-412.
43. Shvarts A., Steegenga W.T., Riteco N., van Laar T., Dekker P., Bazuine M., et al. MDMX: a novel p53-binding protein with some functional properties of MDM2. Embo J. 1996, 15:5349-5357.
44. Stewart M.J., Denell R. Mutations in the Drosophila gene encoding ribosomal protein S6 cause tissue overgrowth. Mol Cell Biol. 1993, 13:2524-2535.
45. Sulic S., Panic L., Barkic M., Mercep M., Uzelac M., Volarevic S. Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response. Genes Dev 2005, 19:3070-3082.
46. Toledo F., Wahl G.M. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer. 2006, 6:909-923.
47. Van den Berghe H., Cassiman J.J., David G., Fryns J.P., Michaux J.L., Sokal G. Distinct haematological disorder with deletion of long arm of no. 5 chromosome. Nature 1974, 251:437-438.
48. Vlachos A., Farrar J., Atsidaftos E., Muir E., Markello T.C., Singh S., et al. 5q- myelodysplastic syndrome, in one of 23 children lacking a known ribosomal gene mutation, masquerading as Diamond Blackfan anemia (DBA) and responding to Lenalidomide. 52nd American Society of Hematology Meeting and Exposition 2010, Abstract LBA-2.
49. Wade M., Wang Y.V., Wahl G.M. The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol. 2010, 20:299-309.
50. Wang Y.V., Wade M., Wahl G.M. Guarding the guardian: Mdmx plays important roles in setting p53 basal activity and determining biological responses in vivo. Cell Cycle 2009, 8:3443-3444.
51. Watson K.L., Konrad K.D., Woods D.F., Bryant P.J. Drosophila homolog of the human S6 ribosomal protein is required for tumor suppression in the hematopoietic system. Proc Natl Acad Sci U S A 1992, 89:11302-11306.
52. Zhang Y., Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009, 16:369-377.
53. Zuckerman V., Wolyniec K., Sionov R.V., Haupt S., Haupt Y. Tumour suppression by p53: the importance of apoptosis and cellular senescence. J Pathol 2009, 219:3-15.